Author

Martha Nason

National Institutes of HealthORCID 0000-0002-0110-881XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:non-human primate· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Alan DodsoniD· 2 shared Alex Van RyiD· 2 shared Amy R. Henry· 2 shared Anna Mychalowych· 2 shared Barbara J. FlynniD· 2 shared Daniel C. DouekiD· 2 shared Dillon R. Flebbe· 2 shared Evan LambiD· 2 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Alan DodsonORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

PathologyJournal of VirologyPeer-reviewedJun 24, 2025

The role of Nef in the long-term persistence of the replication-competent HIV reservoir in South African women

Sherazaan D. Ismail, Shorok Sebaa, Bianca Abrahams…·Andrew D. Redd

This study investigates how HIV-1 Nef's ability to downregulate MHC-I affects the size of the replication-competent viral reservoir in South African women on ART, finding a significant association between MHC-I downregulation and reservoir size.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologyNature ImmunologyPeer-reviewedSep 3, 2024

Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates

Matthew Gagné, Barbara J. Flynn, Shayne F. Andrew…·Robert A. Seder

This study shows that mucosal adenoviral-vectored vaccines provide durable protection against XBB.1.16 infection in nonhuman primates, outperforming intramuscular boosting in reducing virus replication in both upper and lower airways.

78 citationstop 1%

non-human primateexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintNov 22, 2023

Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates

Juan I. Moliva, Shayne F. Andrew, Barbara J. Flynn…·Nancy J. Sullivan

This study shows a gorilla adenovirus-based vaccine provides durable immunity against SARS-CoV-2 in both airways of non-human primates, with enhanced protection from aerosol delivery and prime-boost regimens.

5 citations

non-human primateproteomics

𝕏 PostBluesky